Although our preliminary results have revealed that FOXM1 induced metastasis and drug-resistance of CRC cells (Figure 1G–1Q), this was not the case in DVL2 silencing CRC cells (Figure 5D–5I). This evidence concerns the gene FOXM1 and colorectal carcinoma.